New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 2, 2014
08:06 EDTOHRPOhr Pharmaceutical closes SKS Ocular acquisition
Ohr Pharmaceutical announced the closing of its previously announced acquisition of the assets of SKS Ocular. In connection with this transaction, three of the cofounders of SKS Ocular are being appointed to senior management and advisory roles at Ohr. Jason Slakter has been appointed Chief Medical Officer and is expected to join the Board of Directors. Glenn Stoller has been appointed Chief Scientific Officer. Peter Kaiser will serve as senior vice president of product development.
News For OHRP From The Last 14 Days
Check below for free stories on OHRP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 22, 2014
07:25 EDTOHRPOhr Pharmaceutical management to meet with Brean Capital
Subscribe for More Information
July 11, 2014
16:14 EDTOHRPVisium Asset reports 5.2% passive stake in Ohr Pharmaceutical

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use